📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. (2021)

First Author: Gulati K

Attributed to: The role of P2X7 in Autoimmune Vasculitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.kint.2021.08.025

PubMed Identifier: 34560140

Publication URI: http://europepmc.org/abstract/MED/34560140

Type: Journal Article/Review

Volume: 100

Parent Publication: Kidney international

Issue: 6

ISSN: 0085-2538